S-237-119
Placed on Senate Legislative Calendar under General Orders. Calendar No. 78.
Sponsored by Amy Klobuchar (D-MN)
What it does
This bill would create a legal presumption that certain cancers (like leukemia, lung cancer, and mesothelioma) suffered by police officers, firefighters, and other public safety officers were caused by on-the-job exposure to carcinogens, making survivors and disabled officers eligible for federal death and disability benefits under the Public Safety Officers' Benefits program. It sets eligibility rules (minimum years of service, diagnosis timing) and requires the program's Director to periodically update the list of qualifying cancers. It also expands confidentiality protections for information submitted to the program and allows retroactive claims back to 2020.
Who benefits
Police officers, firefighters, and other public safety officers diagnosed with qualifying cancers, and their surviving families who would gain easier access to federal death and disability benefits without having to individually prove workplace causation. Labor unions and advocacy groups representing first responders would also benefit from the codified presumption.
Who is hurt
The federal Public Safety Officers' Benefits program would bear increased claims volume and payouts, potentially straining program funding. Claimants whose cancers are not on the qualifying list, or who cannot meet the service/diagnosis timing windows, would not benefit and may still face the prior burden of proof. Taxpayers indirectly bear the cost of expanded federal benefit payments.
Supporters argue
Supporters argue that public safety officers face well-documented elevated cancer risks from exposure to smoke, chemicals, and other carcinogens during their careers, and that requiring individual officers or grieving families to prove causation in each case is unreasonably burdensome. They contend the bill follows established science from agencies like NIOSH and mirrors state-level presumptive cancer laws already adopted for firefighters, ensuring families receive support without lengthy adversarial claims processes.
Opponents argue
Opponents argue that broad presumptive eligibility covering twenty types of cancer could lead to claims where exposure was not the actual cause, straining the federal benefits program's finite resources and potentially diverting funds from clearer-cut cases. They contend that a retroactive claims window back to 2020 and open-ended authority for the Director to keep adding new cancers by rule creates unpredictable, expanding federal financial exposure without full congressional review of each addition.